González-Peñas, Javier
de Hoyos, Lucía
Díaz-Caneja, Covadonga M.
Andreu-Bernabeu, Álvaro
Stella, Carol
Gurriarán, Xaquín
Fañanás, Lourdes
Bobes, Julio
González-Pinto, Ana
Crespo-Facorro, Benedicto
Martorell, Lourdes
Vilella, Elisabet
Muntané, Gerard
Molto, María Dolores
Gonzalez-Piqueras, Jose Carlos
Parellada, Mara
Arango, Celso
Costas, Javier
Funding for this research was provided by:
Instituto de Salud Carlos III (JR19/00024)
Article History
Received: 16 November 2022
Accepted: 12 September 2023
First Online: 19 September 2023
Competing interests
: Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Dr. Crespo-Facorro has received honoraria (advisory board and educational lectures) and travel expenses from Takeda, Menarini, Angelini, Teva, Otsuka, Lundbeck and Johnson &; Johnson. He has also received unrestricted research grants from Lundbeck. Dr. Díaz-Caneja has received honoraria from AbbVie, Sanofi, and Exeltis. The rest of the authors do not report any conflicts of interest related to this work.